Innovating Works

EVERSENS

Activa
NOA: NOA a disruptive portable device to monitor asthma EVERSENS tramitó un H2020: H2020-SMEInst-2016-2017 In Europe, about 30 million children and adults under 45 years old have asthma. There is no cure for asthma, it is a chronic disease. Asthma...
2017-05-17 - 2017-11-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.